A Conservative Pharma with 20% Margins and 8% Yield—Yet Deeply Discounted

Last year, we highlighted several deep value stocks, including a few from the medical sector. Notably, two names— IVD Medical (SEHK:1931) and Jacobson Pharma (SEHK:2633)—delivered outstanding returns of 58% and 122% respectively over the past year (excluding dividends).

Recently, Chinese pharmaceutical and biotech stocks have been rallying. Despite this run-up, we’ve uncovered another deep value opportunity in the same space—a stock that still trades below its cash and real estate value while offering a consistent 8% dividend yield.